LakeShore Biopharma Co., Ltd. (LSB)
(Delayed Data from NSDQ)
$0.73 USD
-0.09 (-10.98%)
Updated Aug 1, 2025 03:52 PM ET
After-Market: $0.71 -0.02 (-2.74%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, LakeShore Biopharma Co., Ltd. has a market cap of $9.26M, which represents its share price of $1.00 multiplied by its outstanding shares number of 9.31M. As a small-cap company, LSB's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LSB 0.73 -0.09(-10.98%)
Will LSB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LSB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LSB
Catalent (CTLT) Tops Q4 Earnings and Revenue Estimates
Sol-Gel Technologies Ltd. (SLGL) Surpasses Q2 Earnings and Revenue Estimates
LSB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Invivyd, Inc. (IVVD) Reports Q2 Loss, Lags Revenue Estimates
Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Tops Revenue Estimates
Other News for LSB
LakeShore Biopharma GAAP EPS of -RMB5.22, revenue of RMB615M
LakeShore Biopharma Announces Fiscal Year 2025 Financial Results | LSB Stock News
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Why AES Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket